Is there an age limit in the treatment of hyperlipidemia?
Kaffarnik, H.
Die Medizinische Welt 33(17): 651
1982
ISSN/ISBN: 0025-8512 PMID: 7098829 Document Number: 184184
Document emailed within 1 workday
Related Documents
Rózański, J. 2000: The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia Annales Academiae Medicae Stetinensis 46: 177-187Gérvas, J.; Pérez Fernández, M. 2005: Which is the limit of the provision of services close to patients? The limit is marked by the tension between "the boatman syndrome" and "the cat syndrome" Medicina Clinica 124(20): 778-781
Vanhanen, H. 2004: Blocking the absorption of cholesterol in the treatment of hyperlipidemia--old and new ways of treatment Duodecim; Laaketieteellinen Aikakauskirja 120(9): 1105-1110
Haraldsen, M. 1996: Treatment of hyperlipidemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(1): 112
Stone, W.L.; Chin, T.K. 2001: Drugs for the treatment of hyperlipidemia Idrugs: the Investigational Drugs Journal 4(7): 788-794
Noseda, G. 1990: Drug treatment of hyperlipidemia Therapeutische Umschau. Revue Therapeutique 47(6): 499-508
Weintraub, M.; Grosskopf, I.; Rubinstein, A. 1995: Principles of dietary treatment in hyperlipidemia Harefuah 128(9): 556-561
Tonstad, S.; Leren, T.P.; Ose, L. 1997: Diagnosis and treatment of severe hyperlipidemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(29): 4241-4244
Maxwell, M.H.; Heber, D. 1990: Nutritional treatment of hyperlipidemia and obesity Cardiovascular Clinics 20(3): 149-156
Tanaka, K.; Honjo, H. 2001: Clinical feature and treatment of the postmenopausal hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 766-770
Cook, G.C. 1995: Malaria prophylaxis. Mefloquine toxicity should limit its use to treatment alone Bmj 311(6998): 190-1; Author Reply 192
Stratmann, F.W. 1982: What are the possibilities in the treatment of primary hyperlipidemia in diabetes mellitus? Die Medizinische Welt 33(17): 651
Panchenko, V.M.; Ershov, A.A.; Isaev, V.A.; ZImovchenko, G.S.; Chernova, G.I. 2001: Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus Klinicheskaia Meditsina 79(6): 47-49
Boberg, J.; Gustafson, A. 1970: Serum-lipid reducing principles--possibilities for treatment. 2. Classification of hyperlipidemia Lakartidningen 67: Suppl Iv: 40+
Knight, R.J.; Vathsala, A.; Schoenberg, L.; Camel, S.; Weinberg, R.B.; Goldstein, R.A.; Lewis, R.M.; van Buren, C.T.; Kahan, B.D. 1992: Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification Transplantation 53(1): 224-225
Drouin, P.; Gay, G.; Pointel, J.P.; Sauvanet, J.P.; Debry, G. 1975: Long-term treatment of hyperlipidemia (apropos of 32 cases observed for 6-36 months) Semaine des Hopitaux. Therapeutique 51(9): 449-455
Buchwald, H.; Moore, R.B.; Varco, R.L. 1974: Surgical treatment of hyperlipidemia. 3. Clinical status of the partial ileal bypass operation Circulation 49(5): I22-I37
Caramelli, B.; de Bernoche, C.Y.; Sartori, A.M.; Sposito, A.C.; Santos, R.D.; Monachini, M.C.; Strabelli, T.; Uip, D. 2001: Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 5(6): 332-338
Larsen, M.L.; Blaabjerg, O.; Hørder, M.; Haghfelt, T.; Grinsted, P. 1989: Deliberations on the future organization of diagnostic and treatment control of hyperlipidemia. Experiences from the county of Funen Ugeskrift for Laeger 151(8): 483-487
1984: Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis Circulation 69(5): 1067a-1090a